← Back to Screener
West Pharmaceutical Services, Inc. (WST)
Price$269.81
Favorite Metrics
Price vs S&P 500 (26W)-4.52%
Price vs S&P 500 (4W)5.68%
Market Capitalization$19.13B
P/E Ratio (Annual)38.75x
Indicated Dividend Yield (Annual)0.33%
All Metrics
P/CF (Annual)25.35x
Book Value / Share (Quarterly)$44.11
P/TBV (Annual)6.25x
Indicated Dividend (Annual)$0.88
Revenue Growth (3Y)2.12%
Cash Flow / Share (Quarterly)$6.51
Payout Ratio (TTM)12.40%
Price vs S&P 500 (YTD)-5.78%
Gross Margin (TTM)35.91%
Net Profit Margin (TTM)16.06%
EPS (TTM)$6.79
10-Day Avg Trading Volume0.74M
EPS Excl Extra (TTM)$6.79
Revenue Growth (5Y)7.44%
EPS (Annual)$6.79
Dividend / Share (Annual)$0.85
ROI (Annual)14.59%
Gross Margin (Annual)35.91%
Net Profit Margin (5Y Avg)19.38%
Cash / Share (Quarterly)$10.99
P/E Basic Excl Extra (TTM)38.75x
Revenue Growth QoQ (YoY)7.51%
EPS Growth (5Y)8.26%
P/E Normalized (Annual)38.75x
ROA (Last FY)11.56%
Revenue Growth TTM (YoY)6.25%
EBITD / Share (TTM)$10.47
ROE (5Y Avg)20.93%
Operating Margin (TTM)19.03%
Cash Flow / Share (Annual)$6.51
P/B Ratio6.02x
P/B Ratio (Quarterly)6.23x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)6.03x
Net Interest Coverage (TTM)130.12x
ROA (TTM)12.38%
EPS Growth QoQ (YoY)2.52%
EV / EBITDA (TTM)24.38x
EPS Incl Extra (Annual)$6.79
Current Ratio (Annual)3.02x
Quick Ratio (Quarterly)2.34x
3-Month Avg Trading Volume0.90M
52-Week Price Return25.31%
EV / Free Cash Flow (Annual)39.56x
P/E Incl Extra (TTM)38.75x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$44.00
P/S Ratio (Annual)6.22x
Asset Turnover (Annual)0.72x
52-Week High$322.34
Operating Margin (5Y Avg)22.38%
EPS Excl Extra (Annual)$6.79
CapEx CAGR (5Y)10.39%
Tangible BV CAGR (5Y)11.68%
26-Week Price Return-0.53%
Quick Ratio (Annual)2.34x
13-Week Price Return-2.35%
Total Debt / Equity (Annual)0.07x
Current Ratio (Quarterly)3.02x
Enterprise Value$18,549.83
Revenue / Share Growth (5Y)8.34%
Asset Turnover (TTM)0.77x
Book Value / Share Growth (5Y)11.97%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)4.80x
Pretax Margin (Annual)19.55%
Cash / Share (Annual)$10.99
3-Month Return Std Dev36.60%
Gross Margin (5Y Avg)37.93%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)2.99%
EBITDA Interim CAGR (5Y)6.86%
ROE (Last FY)15.54%
Net Interest Coverage (Annual)128.54x
EPS Basic Excl Extra (Annual)$6.79
P/FCF (TTM)40.80x
Receivables Turnover (TTM)5.40x
EV / Free Cash Flow (TTM)39.56x
Total Debt / Equity (Quarterly)0.07x
EPS Incl Extra (TTM)$6.79
Receivables Turnover (Annual)5.29x
ROI (TTM)15.59%
Dividend Growth Rate (5Y)5.48%
P/S Ratio (TTM)6.22x
Pretax Margin (5Y Avg)22.69%
Revenue / Share (Annual)$42.28
Tangible BV / Share (Annual)$44.00
Forward P/E33.15x
Free OCF CAGR (5Y)9.48%
Price vs S&P 500 (52W)-4.52%
P/E Ratio (TTM)38.75x
EPS Growth TTM (YoY)1.59%
Year-to-Date Return-3.14%
5-Day Price Return3.08%
EPS Normalized (Annual)$6.79
ROA (5Y Avg)15.35%
Net Profit Margin (Annual)16.06%
Month-to-Date Return6.33%
Cash Flow / Share (TTM)$8.90
EBITD / Share (Annual)$8.15
EPS Growth (3Y)-4.22%
Operating Margin (Annual)19.03%
LT Debt / Equity (Annual)0.06x
P/CF (TTM)25.35x
ROI (5Y Avg)19.34%
P/E Excl Extra (TTM)38.75x
LT Debt / Equity (Quarterly)0.06x
EPS Basic Excl Extra (TTM)$6.79
P/TBV (Quarterly)6.25x
Payout Ratio (Annual)12.40%
P/B Ratio (Annual)6.23x
Dividend / Share (TTM)$0.85
Inventory Turnover (TTM)4.80x
Pretax Margin (TTM)19.55%
Book Value / Share (Annual)$44.11
Price vs S&P 500 (13W)-3.04%
Net Margin Growth (5Y)-0.09%
Dividend Yield (TTM)0.32%
Beta1.10x
P/FCF (Annual)40.80x
Revenue / Share (TTM)$42.28
ROE (TTM)16.68%
52-Week Low$193.05
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.05
4.04
4.04
4.04
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
GMEDGLOBUS MEDICAL INC | 4.34x | 30.08% | 67.41% | 20.33% | $92.76 |
About
West Pharmaceutical Services supplies critical packaging and delivery systems to the pharmaceutical, biotechnology, and generic drug industries. Its products include elastomer-based packaging components, nonglass containment solutions, and auto-injectors for biologics, GLP-1 agonists, and small-molecule drugs. The company derives approximately 80% of revenue from proprietary products and 20% from contract manufacturing, with 55% of revenue from international markets.